Combination and transformation of toxin and blood stasis in etiopathogenesis of thrombotic cerebrocardiovascular diseases

Journal of Chinese Integrative Medicine

Volumn 6, Issue 11, 2008, Pages 1105-1108

  Shi, Da Zhuo ^a   Xu, Hao ^b   Yin, Hui Jun ^a   Zhang, Jing Chun ^a   Chen, Ke Ji ^a  

^a XIYUAN HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Blood stasis; Cardiovascular diseases; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; TOXIN;

ARTICLE; ATHEROSCLEROSIS; BIOTRANSFORMATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINESE MEDICINE; HEMOSTASIS; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; TISSUE NECROSIS;

CORONARY THROMBOSIS; HUMANS; INTRACRANIAL THROMBOSIS; MEDICINE, CHINESE TRADITIONAL; THROMBOSIS;

EID: 56849114847     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20081102     Document Type: Article

References (15)

1. Chen KJ, Li LD, Weng WL, et al. Studies of blood stasis syndrome and activating blood circulation. Zhongguo Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi. 2005; 3(1): 1-2. Chinese.
2. Li PT, Wang YY, Huang QF. The hypothesis of the injury of brain collaterals by toxins and its theoretical and practical significance. Beijing Zhong Yi Yao Da Xue Xue Bao. 2001; 24(1): 1-6. Chinese with abstract in English.
3. Chi MY. Integration of Chinese and Western medicine thrombology. Beijing: People's Medical Publishing House. 2004: 1-5. Chinese.
4. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003; 23(12): 2131-2137.
5. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002; 8(11): 1227-1234.
6. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107 (3): 499-511.
7. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995; 92(5): 1084-1088.
8. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2005; 25 (10): 2043-2053.
9. Li JZ. Attention to arterial thrombotic diseases. Zhonghua Nei Ke Za Zhi. 2006; 45(1): 2-3. Chinese.
10. Porter TR, Li S, Oster R, et al. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol. 1998; 82(10): 1173-1177.
11. Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol. 1995; 76 (12): 861-368.
12. Wei JL. Hypothesis on the relationship between toxic heat and apoplexy. Beijing Zhong Yi Yao Da Xue Xue Bao. 2003; 26(1): 7-11. Chinese.
13. Lu XH. Clinical effect and mechanism on treating unstable angina pectoris by Huardian Jiedu Capsule. Shandong Zhong Yi Yao Da Xue Xue Bao. 2005; 29(6): 457-460. Chinese with abstract in English.
14. Wen C, Xu H, Huang QF, et al. Effects of herbs of activation blood on atherosclerotic plaque morphology in ApoE gene-deficient mice. Zhongguo Bing Li Sheng Li Za Zhi. 2005; 21(8): 1640. Chinese.
15. Wen C, Xu H, Huang QF, et al. Effect of drugs for promoting blood circulation on blood lipids and inflammatory reaction of atherosclerotic plaques in ApoE gene deficiency mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005; 25 (4): 345-349. Chinese with abstract in English.